post thrombotic syndrome - search results
If you're not happy with the results, please do another search
Contemporary venous intervention reduces post-thrombotic syndrome in initial CLEAR-DVT analysis
In an initial cohort of patients enrolled in the CLEAR-DVT study, contemporary venous intervention resulted in an open vein, which reduced post-thrombotic syndrome (PTS)....
Study suggests Villalta scale may better capture impact of post-thrombotic syndrome on patient-reported QoL...
In a comparison of two clinical scales that assess quality of life (QoL) in post-thrombotic syndrome, Angela Lee (McGill University, Montreal, Canada) and colleagues...
C-TRACT trial on image-guided procedures for mitigating post-thrombotic syndrome partners with AVF
Writing to members of the American Venous Forum (AVF), president Brajesh K Lal (Baltimore, USA), has revealed that the AVF has established a partnership...
One-year results of ACCESS PTS study brings “hope” for post-thrombotic syndrome patients
The one-year results of the ACCESS PTS trial have shown that EKOS therapy (BTG) statistically improves post-thrombotic syndrome scores and sequelae as well as...
Study sees 42% of patients without post-thrombotic syndrome misclassified with Villalta scale
The common diagnosis of post-thrombotic syndrome (PTS) includes a history of deep venous thrombosis and a Villalta Scale score of four or above. However, a...
ACCESS PTS study demonstrates efficacy of EKOS therapy for post-thrombotic syndrome
The results of the ACCESS PTS trial have been presented at the Society for Vascular Medicine 28th Annual Scientific Sessions (14–17 June, New Orleans,...
“Good” patency rates with dedicated venous stents across the inguinal ligament in post-thrombotic syndrome
The use of dedicated nitinol venous stents across the inguinal ligament shows “good outcomes” in terms of patency but reinterventions may be required, according...
EKOS initiates study in patients with chronic deep vein thrombosis and post-thrombotic syndrome
EKOS Corporation has announced the start of patient enrolment for the Accelerated thrombolysis for post-thrombotic syndrome using the EkoSonic endovascular system (ACCESS PTS) study.
The...
Catheter-directed thrombolysis reduces risk of post-thrombotic syndrome in patients with DVT in the lower...
Researchers from Norway have found that additional treatment with catheter-directed thrombolysis (CDT), when compared to standard treatment of oral anticoagulation therapy and elastic compression...
CHEST releases new guidelines for antithrombotic therapy for VTE disease
The American College of Chest Physicians (CHEST) recently released new clinical guidelines for venous thromboembolism (VTE) management, “Antithrombotic therapy for VTE disease: Second update...
CAVA: Catheter-directed thrombolysis does not change post-thrombotic risk for iliofemoral deep vein thrombosis patients
Additional ultrasound-accelerated catheter-directed thrombolysis (CDT) does not change the risk of post-thrombotic syndrome in patients with acute iliofemoral deep vein thrombosis (DVT) at one-year...
Identifying standard practices of antithrombotic therapy post-venous stenting
Venous stenting has evolved over the last 15 years, quickly becoming an established procedure, with Class II recommendations from the American Heart Association and...
Medtronic Abre stent receives US FDA approval to treat venous outflow obstruction
Medtronic today announced it has received US Food and Drug Administration (FDA) approval for the Abre venous self-expanding stent system. This device is indicated...
Examining the viability of interventional treatment for iliofemoral DVT
ATTRACT compared outcomes following pharmacomechanical thrombolysis (PMT) versus standard medical therapy (SMT), and while no benefit with PMT was demonstrated for femoropopliteal deep vein...
Thrombolex announces 510(k) clearance of Bashir catheter systems for thromboembolic disorders
Thrombolex has announced that the US Food and Drug Administration (FDA) has cleared the Bashir Endovascular Catheter (BEC) for the controlled and selective infusion...
JETi registry provides “remarkable results” for peripheral thrombectomy system
Presenting “remarkable results” from the JETi registry—a prospective, multicentre, observational study which collected real-world data on the safety, performance and clinical benefits of the...
Primary patency after venous stenting best in NIVL patients, study finds
A recent study concludes that non-thrombotic iliac vein lesion (NIVL) patients have better primary patency after venous stenting than patients with venous thrombotic disorders....
AVF 2023: One-year analysis of CLOUT registry reveals “significant and sustained” long-term clinical improvements
Interim one-year outcomes from the multicentre, prospective, single-arm CLOUT registry investigating use of the ClotTriever thrombectomy system (Inari Medical) in all-comer patients with deep...
ABRE 36-month results show sustained patency and clinical improvements in complex venous disease patients
Stephen Black (London, UK) talks to Venous News about the key 36-month results from the ABRE study, which evaluated the safety and effectiveness of the Abre venous...
Meta-analysis of PTS finds one in five risk of long-term symptoms following isolated distal...
A meta-analysis is first to report the pooled risk of post-thrombotic syndrome (PTS) after isolated distal deep vein thrombosis (DVT). Researchers revealed a one...
Early results and expert experience positive for the BeYond dedicated venous stent
This advertorial is sponsored by Bentley.
Launched in July 2020, the BeYond Venous self-expanding stent system (Bentley InnoMed GmbH) now has early clinical data and...
SIR deems endovascular management acceptable treatment option for certain iliofemoral DVT patients
The Society of Interventional Radiology (SIR) published a position statement deeming endovascular thrombus removal “an acceptable treatment option in selected patients with acute iliofemoral...
Thrombectomy for DVT associated with reduced ICU cost when compared with thrombolysis
A retrospective review, presented as a late-breaking clinical trial at The VEINS (Venous Endovascular Interventional Strategies) 2022 (30–31 October, Las Vegas, USA), indicates that...
Mechanical thrombectomy for DVT: Randomised data needed to boost growing evidence base
Two datasets presented during the late-breaking clinical trials session at The VEINS (Venous Endovascular Interventional Strategies) 2022 (30–31 October, Las Vegas, USA)—the latest results...
ABRE clinical study 36-month data show sustained effectiveness of Abre venous self-expanding stent system
Medtronic has announced the 36-month final results from the ABRE clinical study. The purpose of the ABRE clinical study was to evaluate the safety...
Inari Medical announces randomised controlled trial evaluating clinical outcomes of the ClotTriever system in...
Inari Medical has announced planned enrolment of the DEFIANCE randomised controlled trial (RCT), which is designed to compare the clinical outcomes of patients with...
Retrospective study is “first to systematically explore predictors of venous stent occlusion”
New data indicate that venous stent failure “may be predicted by low peak flow velocity and post-thrombotic changes in inflow veins” and that endovascular...
Key differences in presentation, outcomes for distal versus proximal DVT uncovered
A new study highlights key differences in clinical features and comorbidities, as well as short-term and also long-term outcomes for patients with distal deep...
Optimed announces the presentation of two prospective venous stent trials at LINC 2022
Optimed recently announced the presentation of two prospective, multicentre trials evaluating the performance and effectiveness of their venous stent systems at the Leipzig Interventional...
“Excellent outcomes” for Zilver Vena® venous stent sustained out to three years in challenging...
This advertorial is sponsored by Cook Medical. A downloadable version can be found here.
The Zilver Vena venous self-expanding stent system (Cook Medical) is associated...
AVF 2022: Six-month CLOUT data indicate ClotTriever can effectively remove full spectrum of thrombus
Six-month outcomes from the ongoing CLOUT registry demonstrate the “safety and efficacy” of the ClotTriever thrombectomy system (Inari Medical) in a real-world deep vein...
Blueflow venous stent for chronic iliofemoral venous disease “offers favourable primary patency”
Deep venous stenting with the Blueflow venous stent (Plus Medica) offers favourable primary patency, and is associated with significant continued improvement of symptom severity...
ESVS publishes 2022 guidelines on management of chronic venous disease of the lower limb
The European Society for Vascular Surgery (ESVS) has released 2022 clinical practice guidelines on the management of chronic venous disease (CVD) of the lower...
ESVS CVD guideline writing committee “entirely renews structure” of recommendations
The European Society for Vascular Surgery (ESVS) has released 2022 clinical practice guidelines on the management of chronic venous disease (CVD) of the lower...
NIH grant sets Mercator research underway for local anti-inflammatory DVT therapy
Mercator MedSystems has recently announced that the DEXTERITY trials research has begun under a technology transfer grant for approximately $300,000 funded by the National...
European College of Phlebology: Supporting phlebology in Europe
This article is sponsored by the European College of Phlebology.
It is a fact that the incidence of venous disease is rising; currently, 25% of...
Researchers find little benefit to stenting for degree of stenosis in CIVO patients
A new study suggests that the degree of intravascular ultrasound (IVUS)-determined iliofemoral venous stenosis does not appear to affect the initial clinical presentation, clinical-etiologic-anatomic-pathophysiological...
Iliac vein stenting leads to “significant long-term improvements” in patients’ quality of life
Rachael Morris (London, UK) talks to Venous News about VEINES QoL/Sym—a venous disease-specific quality of life (QoL) questionnaire for patients with chronic venous insufficiency—as...
Iliac vein stenting for chronic venous obstruction “significantly” improves venous disease-specific quality of life
Venous disease-specific quality of life (QoL), as measured by the VEINES (Venous insufficiency epidemiological and economic study)-QoL/Sym, improves significantly after iliac vein stenting for...
CLOUT registry: Inari Medical announces positive interim results from first 250 real-world DVT patients...
Inari Medical today announced "strongly positive" interim results from the first 250 deep vein thrombosis (DVT) patients enrolled in the CLOUT (ClotTriever outcomes) registry....
Recent advances in VTE management provide much-needed clarity, but more needs to be done
Manjit Gohel (Cambridge, UK) and Stephen Black (London, UK) write that several recent advances in the management of venous thromboembolism (VTE) have provided clarity...
Joseph Caprini receives first CX Venous Lifetime Achievement Award, as speakers recognise the need...
As evolving treatment modalities offer the potential for improved outcomes in patients with deep venous disease, the importance of patient selection and the need...
Vetex Medical announces positive one-year outcomes for ReVene thrombectomy catheter
Vetex Medical has announced positive one-year outcomes from a European clinical study of the ReVene thrombectomy catheter. In patients with iliofemoral vein thrombus, the...
Three-year data add to growing body of clinical evidence in support of VICI Venous...
This advertorial is sponsored by Boston Scientific.
The VICI Venous Stent System (Boston Scientific) is associated with excellent primary patency rates, with concomitant symptomatic improvement...
VTE management in COVID-19: “Use evidence-based prophylaxis and enrol patients in a clinical trial”
Venous thromboembolism (VTE) in COVID-19 patients was a key topic on the agenda of The VEINS (Venous Endovascular INterventional Strategies) session at VIVA 2020...
Interview: New registry data provide “high-quality answers” on thromboembolic complications in hospitalised COVID-19 patients
Describing the Northwell CORE-19 registry as “the largest prospective registry of thromboembolic complications in hospitalised COVID-19 patients in the post-hospital discharge period,” lead investigator...
Innovation continues in thrombolytic-free thrombectomy
In this article for Venous News, Stephen A Black discusses innovation in the field of thrombolytic-free thrombectomy. He considers "exciting" new developments in mechanical-only...
Braided as compared with laser-cut nitinol stents achieve favourable primary patency at 12 months...
In a recent analysis of 150 patients with post-thrombotic syndrome included in the Swiss and Arnsberg venous stent registries, braided as compared with laser-cut...
CX 2020 LIVE: Overwhelming 91% of specialist audience favours venous stents
A poll of an enthused audience of venous specialists during the CX 2020 LIVE Deep Venous Disease Consensus session found that 91% of them were in...
ABRE study meets primary safety and effectiveness endpoints
Medtronic has announced the first-ever results from the ABRE clinical study assessing the safety and effectiveness of the investigational Abre venous self-expanding stent system...
At six months, adjunctive mechanical thrombectomy associated with higher patency and lower incidence of...
A recent systematic review and meta-analysis showed that, in patients with iliofemoral deep vein thrombosis (DVT), percutaneous mechanical thrombectomy was associated with a higher...
VEITH 2019: Abre venous stent study baseline demographic data presented
This video is only available in selected geographies
Stephen Black (London, UK) talks to VEITHtv about how the dedicated venous open-cell nitinol Abre stent (Medtronic)...
A Deeper Dive into the Venovo™ Venous Stent System
Venous News talks with Gerard O'Sullivan, FSIR, FEBIR, University College Hospital, Galway, Ireland. This article is supported by BD Interventional.
Disclosures: Dr. Gerard O'Sullivan reports...
COVID-19: what will be the fallout for patients with venous disease?
Manj Gohel, Stephen Black and Alun Davies consider the impact of the COVID-19 pandemic on patients with venous disease. They conclude: "Once the acute...
Elder statesman of venous disease delivers golfing metaphor for fortitude, wellness
As a podium talk at the annual meeting of the American Venous Forum (VENOUS 2020; 3–6 March, Amelia Island, USA), it represented a bit...
Contralateral limb improvement after unilateral iliac vein stenting argues against simultaneous bilateral stenting
A retrospective review of patients presenting with bilateral obstructive iliofemoral venous lesions has shown that contralateral limb symptoms improve following stenting of the worse...
IVUS helps to reduce radiation exposure “significantly” for patients undergoing venous stenting
Michael Lichtenberg (Arnsberg, Germany) talks to BLearning Venous at LINC 2020 (Leipzig Interventional Course; 28–31 January 2020, Leipzig, Germany) about the rationale behind his...
Initial results from first-in-man trial of prosthetic VenoValve demonstrate promise
Initial results of an ongoing first-in-man study in Colombia, that saw the implantation of a prosthetic venous valve in 15 patients, have demonstrated an...
Raghu Kolluri
Following his recent appointment as president of the Society for Vascular Medicine (SVM), Raghu Kolluri (Columbus, USA) speaks to Venous News about how the...
Where does the CAVA trial leave early thrombus removal for iliofemoral DVT?
Results from the Dutch CAVA trial were published recently in The Lancet Haematology and, at first glance, this is another trial that failed to...
ATTRACT analysis finds improved quality of life for iliofemoral DVT patients treated with PCDT
An analysis of data from the ATTRACT trial, published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVSVL), reveals that quality of...
LUPA study confirms effectiveness of accelerated leg ulcer pathway in an urban population
“The goal needs to remain on improving healing, but also reduced recurrence in the long term,” said Stephen Black (Guy’s and St Thomas’ Hospital,...
First look at CLOUT registry reveals over 75% of DVT patients have near-complete clot...
David J. Dexter, (Sentara Healthcare, Norfolk, VA, USA), principal investigator of the CLOUT registry using the ClotTriever Mechanical Thrombectomy System (Inari Medical) for treatment...
VIVA 2019: Open vein hypothesis has “validity” for DVT patients, but other factors at...
Suresh Vedantham (St Louis, USA) talks to BLearning Venous after winning the prestigious VEINS award at VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las...
Clinical data on the ClotTriever system demonstrates efficacy for DVT treatment
Inari Medical has announced the presentation of early outcomes from the ClotTriever Outcomes Registry (CLOUT) using the ClotTriever Mechanical Thrombectomy System for treatment of...
Most reinterventions following treatment of iliofemoral DVT could be due to “preventable factors”
Analysing the results of a retrospective, single-centre cohort study conducted at Guys and St Thomas’ Hospital, London, UK, Anna Pouncey (Guys and St Thomas’...
Future trials on the management of DVT “have to focus on technical success” following...
Speaking at the annual meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE 2019; 7–11 September, Barcelona, Spain), Stephen Black (Guys and...
Improved instruments required for classification of chronic venous disease
Current classification tools for the diagnosis of chronic venous disease, including acute deep vein thrombosis (DVT) and post-thrombotic syndrome (PTS), include “redundant” elements that...
A look at new preliminary guidelines for superficial vein thrombosis
At the European Society of Vascular Surgery annual meeting (ESVS 2019; 24-27 September, Hamburg, Germany), preliminary venous thrombosis guidelines were presented for the first...
Kurosh Parsi
Kurosh Parsi, incoming president of the International Union of Phlebology, or Union Internationale de Phlebologie (UIP), is an Australian dermatologist, phlebologist and vascular anomalies...
Results of UK study find that Villalta scale is not disease-specific
Evidence from a recent study conducted by Imperial College London, UK has further demonstrated that the Villalta scoring system is not disease-specific and correlates...
Learn more about the 24-month results of the Venovo Venous Stent VERNACULAR trial
Michael Dake (Tucson, Arizona) presented the two-year data from the VERNACULAR trial at CIRSE 2019 on 8 September in Barcelona, Spain.
Dake said: “The 24-month...
Establishing a pathway for the assessment and pre-treatment of venous leg ulcers
In her presentation at the Royal Society of Medicine Venous Forum (RSMVF; 17–19 June, London, UK), consultant vascular surgeon Emma Wilton (Oxford University Hospitals,...
Thrombophilia not an independent risk factor for venous stent patency loss or reintervention
A recent study has concluded that patients with inherited or acquired thrombophilia should not be excluded from ilio-femoral venous stenting, Adam Gwozdz (St Thomas’...
The new Venovo Venous Stent is changing clinical practice
Steven Dubenec (Sydney, Australia) and Gerard O’Sullivan (Galway, Ireland) discuss the impact of dedicated venous stents, in particular the Venovo venous stent (BD, formerly...
Increased risk of VTE found in critically ill H1N1 patients with acute respiratory distress
A new study has found that intensive care unit patients with swine flu (H1N1) and acute respiratory distress syndrome (ARDS) were 33 times more...
Boston Scientific receives US FDA approval for the Vici Venous Stent system
Boston Scientific has announced hat the US Food and Drug Administration (FDA) has approved the Vici venous stent system for the treatment of iliofemoral...
The optimal pathway for acute deep vein thrombosis treatment involves identification, management and surveillance
Prakash Saha (London, UK), speaking during the Venous and Lymphatic Challenges programme at CX (15–18 April, London, UK), outlined the three key steps to...
BD receives US FDA Approval for Venovo venous stent
BD has announced that the US Food and Drug Administration (FDA) has granted premarket approval for the Venovo venous stent, the first stent indicated...
CASSINI trial results inconclusive on rivaroxaban effects in high-risk ambulatory cancer patients
The CASSINI trial found that treatment with rivaroxaban did not significantly reduce the incidence of thromboembolism or death caused by thromboembolism in high-risk ambulatory...
NICE aortic guidelines debate prompts scrutiny of venous guidelines and evidence gaps
At the 2018 Vascular Societies’ Annual Scientific Meeting (VSASM; 27–29 November, Glasgow, UK), Bruce Campbell from Exeter Medical in Exeter, UK, who previously chaired...
VIRTUS 12-month outcomes presented at LINC: Vici stent meets primary endpoints
New 12-month data from the VIRTUS trial demonstrates that patients who were treated with the Vici Venous Stent system (Boston Scientific) for iliac and femoral...
New DVT device completes first-in-human trial
The first-in-human case using the new deep vein thrombosis (DVT) device Vetex thrombectomy catheter (Vetex Medical) has recently been completed in a multicentre study....
New ATTRACT data show catheter-based therapy significantly reduces leg symptoms and PTS severity to...
A new study, recently published online in the journal Circulation, reports on outcomes from a subgroup of 391 patients with acute iliofemoral deep venous...
Ramesh Tripathi
Having worked as a vascular surgeon and venous specialist in several different countries and continents, Ramesh Tripathi has a wide-ranging experience and storied career. He...
VERNACULAR trial 12-month data show successful use of Venovo stent in obstructive lesions
The 12-month results from the VERNACULAR trial have shown that the Venovo venous stent (BD Interventional) is successful when deployed in obstructive iliac and...
Worse outcomes in peripartum compared to non-pregnant women stented for DVT
Peripartum women with deep vein thrombosis (DVT) treated with catheter-directed thrombolysis and venous stenting had significantly increased rates of reintervention and loss of stent patency...
AngioJet thrombectomy can reduce dose and duration of lysis compared to thrombolysis alone
Anna Louise Pouncey revealed at the European Venous Forum annual meeting (EVF; 28–30 June, Athens, Greece) the findings of the GSTT venous team (Guy’s...
New intravascular ultrasound-based scoring system may predict future venous stent failure
To accompany the growing importance of intravascular ultrasound (IVUS) as an adjuvant diagnostic tool when treating deep venous disease, a study sought to create...
Early ultrasound surveillance key to predicting risk of re-intervention in deep stenting patients
An analysis of post-thrombotic disease patients who received a nitinol stent has found that ultrasound surveillance should occur at frequent intervals up to two...
Moving towards a paradigm shift for pelvic venous disorders with launch of International Pelvic...
Treatment of patients with pelvic venous disorders is a “controversial topic,” Kathleen Gibson (Lake Washington Vascular Surgeons, Bellevue, USA) said at the Charing Cross...
CX audience rejects idea that ATTRACT has the final say on thrombolysis in deep...
According to a debate at the Charing Cross Symposium (CX; 24–27 April, London, UK), the vast majority of CX delegates disagree with the view...
Ten patients successfully treated with recently CE-marked venous stent
Medical device company Plus medica has announced that 10 patients have been treated with the company’s blueflow Venous Stent. The first cases were performed...
UIP audience votes against stenting as standard for deep vein obstruction
The deep venous world is wrestling with the question: To stent or not to stent. While the availability of new specialised venous stents is...
Setting the record straight: Clarifying the misconceptions of the ATTRACT trial
A special session during the pre-conference Day of Innovation and Science at the American Venous Forum annual meeting (AVF; 20–23 February, Tucson, USA) presented...
High lysis completeness “guarantees high success rates” of iliac vein stent patency following acute...
A recent study on iliac vein stenting following catheter-directed thrombolysis for deep vein thrombosis (DVT) has shown that technical and clinical success require high...
One-year data from venous stent registry “promising”
Efficacy data from the Arnsberg Registry at 12 months are promising, with high primary patency rates for a dedicated venous stent.
Presenting the data at...
Armando Mansilha
Armando Mansilha is professor of Angiology and Vascular Surgery, Faculty of Medicine at the University of Porto, Porto, Portugal. In this interview with Venous...
Early results of iliocaval reconstruction with stents for venous outflow obstruction patients are encouraging
“Endovascular reconstruction of the chronically obstructed iliocaval venous tract with stents is technically feasible, minimally invasive and has an acceptable safety rate, said James...
Published ATTRACT data call into question validity of the Villalta scale
Following the publication of the ATTRACT trial in the New England Journal of Medicine (NEJM) in December 2017, Venous News spoke to experts in...
Phlebology world heads Down Under for UIP
Venous specialists from around the globe will meet in Melbourne for the much anticipated 2018 World Congress of Phlebology (UIP; 4–8 February, Melbourne, Australia)...
Considering venous thrombosis at unusual sites
At the THE VEINS at VIVA meeting (10–11 September, Las Vegas, USA), Esther Kim (Vanderbilt University Medical Center, Nashville, USA) gave a presentation on venous thrombosis...
New research indicates that stenting below the inguinal ligament does not result in inferior...
Endovascular treatment of iliocaval and infrainguinal post-thrombotic venous obstruction results do not appear to be adversely affected by extension of the iliac vein stents...
Marianne De Maeseneer
Marianne De Maeseneer already wanted to become a doctor by the age of 12, with her imagination captured by the idea of working in...
Thrombosis: Both a physical and psychological event
There are two things you need to know about me. Firstly, I am a health psychologist, with a specialist interest in behaviour change, implementation, and impact....
GARFIELD-VTE Registry sheds light on global heterogeneity of venous thromboembolism patients, treatment and outcomes
The first results from the GARFIELD-VTE (Global anticoagulant registry in the field—venous thromboembolism) were presented at the International Society on Thrombosis and Haemostasis Congress...
ATTRACT results are “a springboard” for future pharmacomechanical thrombolysis research
Data from the randomised controlled ATTRACT trial revealed that the addition of catheter-based intervention to standard-of-care anticoagulation failed to significantly decrease the occurrence of...
ATTRACT fails to meet primary endpoint, but experts agree results are “hypothesis-generating”
Data from the randomised controlled ATTRACT trial revealed that the addition of catheter-based intervention to standard-of-care anticoagulation failed to significantly decrease the occurrence of...
The duplex criteria for paediatric reflux testing
Primary chronic venous disease is poorly documented in paediatric patients, excluding those diagnosed with Klippel-Trenaunay syndrome (KTS) and post-thrombotic syndrome, writes Dawn Coleman. The...
The success of deep venous intervention rests on mid- to long-term outcomes
In this interview, Vascular News speaks to Prakash Saha, King’s College Hospital, London, UK, about the growth of deep venous treatment and how the...
Key clinical questions I would like to see answered in the future of deep...
Therapies in deep venous thrombosis (DVT) have been slow to advance over the past 50 years. Recently, growing awareness and improvements in tools and...
VENITI completes first use of VICI VERTO VENOUS STENT system
The first patient suffering from post-thrombotic syndrome associated with venous outflow obstruction has been treated with the VICI VERTO VENOUS STENT system.
This stent...
When to use intervention for deep venous thrombosis and pulmonary embolism
At the 2016 Leipzig Interventional Course meeting (LINC; 26–29 January, Leipzig, Germany), Michael R Jaff, Boston, USA, discussed the challenges facing intervention for deep...
“We need to find the optimal stent configuration for venous disease”
Rick De Graaf, Department of Radiology, Maastricht University Medical Centre, Maastricht, The Netherlands, presented the results of the first comparative study of four dedicated...
We “still await” the ideal venous stent, despite rapid development in technology
By Athanasios D Giannoukas
Today, venous stenting plays an important role in the treatment of deep venous pathologies. The current indications for its use include acute...
NICE recommends once-daily Lixiana (edoxaban) to treat and prevent adult recurrent deep vein thrombosis...
The National Institute for Health and Care Excellence (NICE), the medicines cost-effectiveness body for England and Wales, has recommended a new treatment to help...
More bleeding with catheter-directed thrombolysis than with standard anticoagulation in deep vein thrombosis
A study published in the Journal of the American Medical Association (JAMA) has found no difference in mortality rates between deep vein thrombosis patients...
Covidien launches next generation Trellis peripheral infusion system
Covidien has announced the commercial launch of its next generation Trellis peripheral infusion system. The redesigned system continues to be the only pharmacomechanical thrombolysis device that enables...
New rotational pharmacomechanical thrombectomy device promising for deep vein thrombosis
A new rotational thrombectomy device is safe and effective in the treatment of acute and subacute deep vein thrombosis in a single session of...
“Filter or no filter” during percutaneous endovenous intervention for deep vein thrombosis
By Mohsen Sharifi
Percutaneous endovenous intervention (PEVI) is increasingly being used in the treatment of massive lower extremity deep vein thrombosis. It utilises a variety...
Genetics of venous disease
By David L Gillespie
Varicose veins are a common condition affecting more than 25 million people in the United States. While the genetic basis of varicose...
Ultrasound-accelerated catheter-directed thrombolysis of acute iliofemoral vein thrombosis remains safe
The use of ultrasound-accelerated catheter-directed thrombolysis to treat acute iliofemoral deep vein thrombosis continues to be feasible and safe, according to a study presented...
Management of deep vein thrombosis
DVT, other than that triggered by trauma or surgery, is now considered to be a chronic disease with a high risk of recurrence.
‘Rapid lysis’ technique could potentially change DVT treatment
Results at the Society of Interventional Radiology's 32nd Annual Scientific Meeting, in Seattle, WA, Dr Mark J Garcia.
Stents may have future in venous disease
Study plans to enrol up to 50 patients with chronic deep venous insufficiency and venous ulcers (present for at least six months)
The art of clotbusting
Clot Lysis and Thrombolytic Therapy
